NILA Comments on Discussion Draft of VALID Act released May 17, 2022
On May 21, 2022, NILA submitted comments to Senator Patty Murray, chair of the Senate Committee on Health, Education, Labor & Pensions (HELP) and Senator Richard Burr, ranking member of the HELP Committee, on the discussion draft of the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. View NILA’s comments here.
Senators Murray, Burr Release Legislation to Support FDA Programs to Lower Costs and Spur Innovation, May 17, 2022, A Press Release from the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP Committee). Click here for story
NILA previously submitted comments on the VALID Act and joined 18 other stakeholder organizations in a letter urging Congress to consider this issue independently of the FDA user fee legislative process.